A carregar...

Antiphospholipid antibodies in patients with dysglycaemia: A neglected cardiovascular risk factor?

BACKGROUND: Cardiovascular disease is a serious complication in patients with dysglycaemia, defined as either type 2 diabetes or impaired glucose tolerance. Research focusing on the identification of potential markers for atherothrombotic disease in these subjects is warranted. The antiphospholipid...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Diab Vasc Dis Res
Main Authors: Ferrannini, Giulia, Svenungsson, Elisabet, Kjellström, Barbro, Elvin, Kerstin, Grosso, Giorgia, Näsman, Per, Rydén, Lars, Norhammar, Anna
Formato: Artigo
Idioma:Inglês
Publicado em: SAGE Publications 2020
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7607409/
https://ncbi.nlm.nih.gov/pubmed/32506943
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1479164120922123
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!